JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M507380200 on October 20, 2005

J. Biol. Chem., Vol. 280, Issue 52, 42508-42514, December 30, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/52/42508    most recent
M507380200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pears, M. R.
Right arrow Articles by Griffin, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pears, M. R.
Right arrow Articles by Griffin, J. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

High Resolution 1H NMR-based Metabolomics Indicates a Neurotransmitter Cycling Deficit in Cerebral Tissue from a Mouse Model of Batten Disease*

Michael R. Pears{ddagger}1, Jonathan D. Cooper§, Hannah M. Mitchison¶, Russell J. Mortishire-Smith||, David A. Pearce**, and Julian L. Griffin{ddagger}2

From the {ddagger}Department of Biochemistry, Tennis Court Road, University of Cambridge, Cambridge CB2 1GA, United Kingdom, the §Pediatric Storage Disorders Laboratory, Department of Neuroscience, Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, United Kingdom, the Department of Paediatrics and Child Health, Royal Free and University College Medical School, Rayne Building, University Street, London WC1E 6JJ, United Kingdom, the ||Merck Sharp and Dohme Research Laboratories, The Neuroscience Research Centre, Terlings Park, Harlow, Essex CM20 2QR, United Kingdom, and the **Center for Aging and Developmental Biology, Aab Institute of Biomedical Sciences, Department of Biochemistry and Biophysics and Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

The neuronal ceroid lipofuscinoses (NCLs) constitute a range of progressive neurological disorders primarily affecting children. Although six of the causative genes have been characterized, the underlying disease pathogenesis for this family of disorders is unknown. Using a metabolomics approach based on high resolution 1H NMR spectroscopy of the cortex, cerebellum, and remaining regions of the brain in conjunction with statistical pattern recognition, we report metabolic deficits associated with juvenile NCL in a Cln3 knock-out mouse model. Tissue from Cln3 null mutant mice aged 1–6 months was characterized by an increased glutamate concentration and a decrease in {gamma}-amino butyric acid (GABA) concentration in aqueous extracts from the three regions of the brain. These changes are consistent with the reported altered expression of genes involved in glutamate metabolism in older mice and imply a change in neurotransmitter cycling between glutamate/glutamine and the production of GABA. Further variations in myo-inositol, creatine, and N-acetyl-aspartate were also identified. These metabolic changes were distinct from the normal aging/developmental process. Together, these changes represent the first documented pre-symptomatic symptoms of the Cln3 mouse at 1 month of age and demonstrate the versatility of 1H NMR spectroscopy as a tool for phenotyping mouse models of disease.


Received for publication, July 7, 2005 , and in revised form, September 2, 2005.

* This work was supported in part by National Institutes of Health Metabolomics Roadmap Initiative Grant R21DK070288-01 and Commission of the European Communities Grant 503051. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Recipient of a Biotechnology and Biological Sciences Research Council Cooperative Awards in Science and Engineering (CASE)-sponsored studentship in conjunction with Merck Sharp and Dohme.

2 Grateful recipient of a University Research Fellowship from the Royal Society and to whom correspondence should be addressed. Tel.: 44-1223-333626; Fax: 44-1223-766002; E-mail: jlg40{at}mole.bio.cam.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cereb CortexHome page
F. Angenstein, L. Hilfert, W. Zuschratter, W. D. Altrock, H. G. Niessen, and E. D. Gundelfinger
Morphological and Metabolic Changes in the Cortex of Mice Lacking the Functional Presynaptic Active Zone Protein Bassoon: A Combined 1H-NMR Spectroscopy and Histochemical Study
Cereb Cortex, April 1, 2008; 18(4): 890 - 897.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.